Dupont Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Dupont Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,500	Closed	-$700	–	220
2023 Q3	$700	Hold	12,500	–	–	﹤0.01%	169
2023 Q2	$1.71K	Hold	12,500	–	–	﹤0.01%	538
2023 Q1	$1.07K	Hold	12,500	–	–	﹤0.01%	664
2022 Q4	$575	Hold	12,500	–	–	﹤0.01%	1289
2022 Q3	$2K	Hold	12,500	–	–	﹤0.01%	1409
2022 Q2	$1K	Hold	12,500	–	–	﹤0.01%	1596
2022 Q1	$3K	Buy	+12,500	New	+$3.25K	﹤0.01%	1638

Dupont Capital Management's BIOSW Position: Q4 2023 in Review

Dupont Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 12,500 shares — an estimated $700 sold.

Dupont Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $3K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Dupont Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Dupont Capital Management sold 12,500 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $700.
Dupont Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Dupont Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $3K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Dupont Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.